Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

RT-PCR Database Analysis for COVID-19 Infections and Re-infection

  • Read more about RT-PCR Database Analysis for COVID-19 Infections and Re-infection

A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years

  • Read more about A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years

A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine SCTV01E-1 in Population Aged Above 18 Years

  • Read more about A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine SCTV01E-1 in Population Aged Above 18 Years

Retinal Vascular Changes in Patients After Coronavirus Disease 2019 (COVID-19)

  • Read more about Retinal Vascular Changes in Patients After Coronavirus Disease 2019 (COVID-19)

Study of Neurological Damage From Coronavirus Disease (COVID-19)

  • Read more about Study of Neurological Damage From Coronavirus Disease (COVID-19)

STS Administration on Coronavirus Disease (COVID-19) Patients in Critical Care

  • Read more about STS Administration on Coronavirus Disease (COVID-19) Patients in Critical Care

A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19

  • Read more about A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19

Investigation of the Persistence of SARS-CoV-2 in the Olfactory Mucosa of Patients With Prolonged Symptoms of COVID-19

  • Read more about Investigation of the Persistence of SARS-CoV-2 in the Olfactory Mucosa of Patients With Prolonged Symptoms of COVID-19

International Survey of Acute Coronavirus Syndromes-COVID-19

  • Read more about International Survey of Acute Coronavirus Syndromes-COVID-19

Evaluation of the Safety, Tolerability, and Reactogenicity of the Baiya SARS-CoV-2 Vax 2 Vaccine for COVID-19 Disease

  • Read more about Evaluation of the Safety, Tolerability, and Reactogenicity of the Baiya SARS-CoV-2 Vax 2 Vaccine for COVID-19 Disease

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 139
  • Page 140
  • Page 141
  • Page 142
  • Current page 143
  • Page 144
  • Page 145
  • Page 146
  • Page 147
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA